Karolinska Development (Sweden) Buy or Sell Recommendation

Macroaxis provides Karolinska Development AB buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Karolinska Development positions. The advice algorithm takes into account all of Karolinska Development AB available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from Karolinska Development buy-and-hold prospective. Please see also Stocks Correlation.

Time Horizon

Risk Tolerance

Execute Advice
Karolinska Development AB -- Sweden Stock  

SEK 5.84  0.26  4.66%

Assuming 30 trading days horizon, and your above average risk tolerance our recommendation regarding Karolinska Development AB is 'Not Rated'.
For the selected time horizon Karolinska Development AB has a risk adjusted performance of 0.065571, jensen alpha of 0.14, total risk alpha of 0.1458, sortino ratio of 0.0 and treynor ratio of 0.68
We provide buy, hold, or sell recommendation to complement the last-minute expert consensus on Karolinska Development AB. Our dynamic recommendation engine harnesses multi - dimensional algorithm to analyze the entity potential to grow using all technical and fundamental data available at the time. To make sure Karolinska Development AB is not overpriced, please verify all Karolinska Development AB fundamentals including its EBITDA, Cash and Equivalents and the relationship between Gross Profit and Net Income .

Returns Distribution Density

Mean Return0.17Value At Risk5.66
Potential Upside3.64Standard Deviation4.02
 Return Density 
Not Rated
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Find Alpha
Equity Screener
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals, sectors and families
Research Equities
Insiders Screener
Find insiders across different sectors to evaluate their impact on performance and growth of their entities
Research Insiders

Current Valuation

Karolinska Development Current Valuation Analysis
Karolinska Development AB is considered the number one company in current valuation category among related companies. After adjusting for long-term liabilities, total market size of Pharmaceuticals And Biosciences industry is now estimated at about 37.76 Billion. Karolinska Development claims roughly 549.29 Million in current valuation contributing just under 2% to equities listed under Pharmaceuticals And Biosciences industry.